Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PharmaMar reported to National Securities Market Commission that Chugai Pharmaceutical had exercised its right to terminate without cause the License, Development and Commercialization Agreement for Zepsyre in Japan entered on December 22nd, 2016.
read more
ICON announced it is working with Practice Fusion to leverage active patient data in support of health research.
read more
Amazon and PillPack have entered into a definitive merger agreement under which Amazon will acquire PillPack.
read more
Lupin and Mylan announced they will partner to commercialize a biosimilar to Enbrel.
read more
Lannett has announced a restructuring and cost reduction plan of its subsidiary, Cody Laboratories, a developer and manufacturer of pain management APIs.
read more
Adents has addressed a compliance issue through its recently introduced, Blockchain-based Adents NovaTrack product.
read more
Leiters has been awarded an outsourcing supply agreement for 503B compounded pharmaceuticals. The 3-year agreement went into effect on June 1, 2018.
read more
Jazz Pharmaceuticals announced a definitive agreement to sell its rights related to Prialt intrathecal infusion to TerSera Therapeutics for $80 million in cash at closing.
read more
Recipharm has announced the launch of its standalone serialization service ahead of the introduction of the EU Falsified Medicines Directive.
read more
BrainStorm Cell Therapeutics has contracted with the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute as a second U.S. manufacturing site to supply NurOwn.
read more
Onco360 has been selected to participate in the limited distribution network of Braftovi and Mektovi for the treatment of patients with unresectable or metastatic melanoma.
read more
Acentrus Specialty has signed a strategic agreement with LicenseLogix to provide license compliance services to Acentrus clients.
read more
Juniper Pharmaceuticals has entered into a definitive agreement with Catalent to acquire all of the outstanding shares of Juniper at a price of $11.50 per share in cash.
read more
Bioanalytical Systems and Seventh Wave Laboratories have signed an asset purchase agreement joining operations to provide broader solutions and greater scientific expertise to clients.
read more
The global clinical trial management market was valued at $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023 according to a recently released report.
read more